Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview.

MLA

Alshememry, Abdullah K., et al. “Recent Nanotechnology Advancements to Treat Multidrug-Resistance Pancreatic Cancer: Pre-Clinical and Clinical Overview.” Frontiers in Pharmacology, vol. 13, Aug. 2022, pp. 01-17. EBSCOhost, https://doi.org/10.3389/fphar.2022.933457.

APA

Alshememry, A. K., Alsaleh, N. B., Alkhudair, N., Alzhrani, R., & Alshamsan, A. (2022). Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview. Frontiers in Pharmacology, 13, 01-17. https://doi.org/10.3389/fphar.2022.933457

Chicago

Alshememry, Abdullah K., Nasser B. Alsaleh, Nora Alkhudair, Rami Alzhrani, and Aws Alshamsan. 2022. “Recent Nanotechnology Advancements to Treat Multidrug-Resistance Pancreatic Cancer: Pre-Clinical and Clinical Overview.” Frontiers in Pharmacology 13 (August): 01-17. doi:10.3389/fphar.2022.933457.